Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00226499
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:34.558866+00:00
Published At
2019-09-23T00:00:00+00:00
Record Updated At
2019-09-23
Results Posted At
2019-09-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Varicella", "Chickenpox Vaccines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-09-23"
protocolSection.identificationModule.nctId
"NCT00226499"
protocolSection.identificationModule.officialTitle
"Study in Healthy Children (\u003c2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals\u0027 Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals\u0027 Combined Measles-Mumps-Rubella-Varicella Vaccine"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-09-23"

Study condition terms

  • Varicella (protocolSection.conditionsModule.conditions)
  • Chickenpox Vaccines (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.